| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,204,032 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-09-19 |
4 |
S |
$75.45 |
$4,802,543 |
D/D |
(63,652) |
432,002 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-09-19 |
4 |
OE |
$7.88 |
$551,250 |
D/D |
70,000 |
495,654 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2008-08-11 |
4 |
S |
$77.23 |
$2,085,210 |
D/D |
(27,000) |
30,462 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2008-08-11 |
4 |
OE |
$51.17 |
$1,491,540 |
D/D |
27,000 |
57,462 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-08-11 |
4 |
S |
$76.96 |
$1,668,185 |
D/D |
(21,676) |
40,209 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-08-11 |
4 |
OE |
$48.06 |
$1,080,083 |
D/D |
21,676 |
61,885 |
|
- |
|
| Vaught Jeffry L |
Exec. VP, R&D |
• – – |
2008-08-07 |
4 |
S |
$76.44 |
$1,342,286 |
D/D |
(17,560) |
48,382 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2008-08-04 |
4 |
S |
$73.59 |
$4,630,724 |
D/D |
(62,926) |
51,396 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2008-08-04 |
4 |
OE |
$48.06 |
$3,102,933 |
D/D |
62,926 |
114,322 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2008-08-04 |
4 |
S |
$73.51 |
$735,100 |
D/D |
(10,000) |
0 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2008-08-04 |
4 |
OE |
$45.23 |
$452,300 |
D/D |
10,000 |
10,000 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2008-08-01 |
4 |
S |
$74.02 |
$740,200 |
D/D |
(10,000) |
0 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2008-08-01 |
4 |
OE |
$11.19 |
$111,870 |
D/D |
10,000 |
10,000 |
|
- |
|
| Egan William P |
Director |
– • – |
2008-03-07 |
4 |
S |
$60.07 |
$511,602 |
D/D |
(8,495) |
400 |
|
- |
|
| Egan William P |
Director |
– • – |
2008-03-07 |
4 |
OE |
$12.38 |
$110,076 |
D/D |
8,895 |
8,895 |
|
- |
|
| Egan William P |
Director |
– • – |
2008-03-07 |
4 |
S |
$60.38 |
$24,160 |
D/D |
(400) |
0 |
|
- |
|
| Egan William P |
Director |
– • – |
2008-03-06 |
4 |
S |
$61.36 |
$67,805 |
D/D |
(1,105) |
0 |
|
- |
|
| Egan William P |
Director |
– • – |
2008-03-06 |
4 |
OE |
$12.38 |
$13,674 |
D/D |
1,105 |
1,105 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2008-02-01 |
4 |
D |
$65.20 |
$24,580 |
D/D |
(377) |
425,654 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops. |
• – – |
2007-12-21 |
4 |
S |
$72.60 |
$521,697 |
D/D |
(7,185) |
40,209 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-19 |
4 |
D |
$73.90 |
$111,220 |
D/D |
(1,505) |
45,435 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-12-19 |
4 |
A |
$73.90 |
$113,289 |
D/D |
1,533 |
30,462 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-19 |
4 |
D |
$73.90 |
$111,220 |
D/D |
(1,505) |
47,394 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-12-19 |
4 |
D |
$73.90 |
$119,496 |
D/D |
(1,617) |
82,583 |
|
- |
|
| Vaught Jeffry L |
Exec. VP & Pres., R&D |
• – – |
2007-12-19 |
4 |
D |
$73.90 |
$111,220 |
D/D |
(1,505) |
65,942 |
|
- |
|
491 Records found
|
|
Page 8 of 20 |
|
|
